Literature DB >> 14727454

Onset signs, clinical course, prognosis, treatment and outcome of adult patients with Adamantiades-Behçet's disease in Greece.

C C Zouboulis1, G Vaiopoulos, N Marcomichelakis, G Palimeris, I Markidou, B Thouas, P Kaklamanis.   

Abstract

OBJECTIVES: To examine the onset signs, clinical course, prognosis, treatment and outcome of Adamantiades-Behçet's disease in adult Greek patients during a 10-year follow-up period, and to compare the results with those of other series reported.
METHODS: The studied population consisted of 82 adult patients (54 male and 28 female) of Greek origin. Patients filled out a standard questionnaire and were followed up regularly. The findings during the follow-up of these patients were compared with those of other series.
RESULTS: The most frequent onset sign was oral aphthae, both in our patients and in those of other published series. Eye involvement, joint involvement, genital ulcers and skin lesions followed in frequency. During a 10-year follow-up differences were observed between men and women, with arthritis being more frequent in females compared to males and with an overall more severe course in males. Eye involvement occurred earlier than neurological and vascular manifestations. A few differences were found in the clinical parameters in comparison to previously reported ethnic series. HLA-B51 positive patients presented an odds ratio of 9.5, the activity index was 5.17 +/- 2.56 and the mean severity score 5.96 +/- 2.32. Early treatment led to improvement of the disease.
CONCLUSION: The pattern of Adamantiades-Behçet's disease in adult Greek patients provides major similarities when compared to patterns in various other national groups.

Entities:  

Mesh:

Year:  2003        PMID: 14727454

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  9 in total

Review 1.  Clinical Immunology Review Series: an approach to the patient with recurrent orogenital ulceration, including Behçet's syndrome.

Authors:  M T Keogan
Journal:  Clin Exp Immunol       Date:  2008-12-11       Impact factor: 4.330

2.  Behçet's disease in Brazilian patients: demographic and clinical features.

Authors:  Zoraida Sachetto; Nazira Mahayri; Rosemeire Holanda Ferraz; Lilian Teresa Lavras Costallat; Manoel Barros Bertolo
Journal:  Rheumatol Int       Date:  2011-04-11       Impact factor: 2.631

Review 3.  Behçet syndrome: from pathogenesis to novel therapies.

Authors:  Gianluigi Mazzoccoli; Angela Matarangolo; Rosa Rubino; Michele Inglese; Angelo De Cata
Journal:  Clin Exp Med       Date:  2014-12-02       Impact factor: 3.984

4.  The natural course and factors affecting severity of Behçet's disease: a single-center cohort of 368 patients.

Authors:  Nilay Ugurlu; Selen Bozkurt; Ali Bacanli; Ayse Akman-Karakas; Soner Uzun; Erkan Alpsoy
Journal:  Rheumatol Int       Date:  2015-06-18       Impact factor: 2.631

Review 5.  Pseudomembranous colitis.

Authors:  Priya D Farooq; Nathalie H Urrunaga; Derek M Tang; Erik C von Rosenvinge
Journal:  Dis Mon       Date:  2015-03-11       Impact factor: 3.800

6.  Adamantiades-Behcet disease (ABD) in northern Greece patients: experience from a single center.

Authors:  P Boura; K Tselios; P Skendros; S Kamali; A Sarantopoulos; M Raptopoulou-Gigi
Journal:  Hippokratia       Date:  2007-10       Impact factor: 0.471

7.  A Case of Neuro-Behcet's Disease Presenting with Central Neurogenic Hyperventilation.

Authors:  Ayham M Alkhachroum; Saba Saeed; Jaspreet Kaur; Tanzila Shams; Michael A DeGeorgia
Journal:  Am J Case Rep       Date:  2016-03-11

8.  Clinical phenotypes of Korean patients with Behcet disease according to gender, age at onset, and HLA-B51.

Authors:  Hee Jung Ryu; Mi Ryoung Seo; Hyo Jin Choi; Han Joo Baek
Journal:  Korean J Intern Med       Date:  2017-01-12       Impact factor: 2.884

9.  Epidemiological, clinical, and therapeutic characteristics of Behçet's disease: a monocentric study in Tunisia.

Authors:  Fatma Daoud; Imène Rachdi; Mehdi Somai; Anissa Zaouak; Houda Hammami; Meriem Ouederni; Rym Maamouri; Hana Zoubeidi; Molka Tougorti; Jihène Ksouri; Besma Ben Dhaou; Zohra Aydi; Samy Fenniche; Monia Cheour; Fatma Boussema
Journal:  Pan Afr Med J       Date:  2021-09-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.